Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?

Molecular Interventions

Volumn 10, Issue 2, 2010, Pages 76-79

  Young, Matthew R ^a   Santhanam, Arti N ^a   Yoshikawa, Noriko ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; MICRORNA; MYELOID DIFFERENTIATION FACTOR 88; PROGRAMMED CELL DEATH 4; TOLL LIKE RECEPTOR 4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; ENZYME ACTIVITY; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

APOPTOSIS REGULATORY PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS; RNA-BINDING PROTEINS;

EID: 77950679650     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.10.2.5     Document Type: Review

References (28)

1. Krichevsky AM and Gabriely G (2009) miR-21: A small multi-faceted RNA. J Cell Mol Med 13:39-53.
2. Garzon R, Calin GA, and Croce CM (2009) MicroRNAs in Cancer. Annu Rev Med 60:167-179.
3. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, and Allgayer H (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intra-vasation and metastasis in colorectal cancer. Oncogene 27:2128-2136.
4. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, and Lund AH (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026-1033.
5. 2-induced injury on cardiac myo-cytes via its target gene PDCD4. J Mol Cell Cardiol 47:5-14 (2009).
6. Karin M (2008) The IκB kinase-a bridge between inflammation and cancer. Cell Res 18:334-342.
7. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, and O'Neill LA (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11:141-147.
8. Lankat-Buttgereit B and Goke R (2009) The tumour suppressor Pdcd4: Recent advances in the elucidation of function and regulation. Biol Cell 101:309-317.
9. Allgayer H (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73:185-191.
10. Yang HS, Jansen A P, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, and Colburn NH (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23:26-37.
11. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, and Colburn NH (2004) A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24:3894-3906.
12. LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, and Colburn NH (2007) Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol 27:147-156.
13. Bohm M, Sawicka K, Siebrasse J P, Brehmer-Fastnacht A, Peters R, and Klempnauer KH (2003) The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22:4905-4910.
14. Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH, and Allgayer H (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110:1697-1707
15. Yang HS, Jansen A P, Nair R, Shibahara K, Verma AK, Cmarik JL, and Colburn NH (2001) A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation. Oncogene 20:669-676. This was the first report to show that PDCD4 activates NF-κB-dependent transcription.
16. Jansen A P, Camalier CE, and Colburn NH (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumori-genesis. Cancer Res 65:6034-6041 (2005).
17. Schmid T, Jansen A P, Baker AR, Hegamyer G, Hagan J P, and Colburn NH (2008) Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res 68: 1254-1260.
18. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, and Allgayer H (2007) Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26:4550-4562.
19. Hilliard A, Hilliard,B, Zheng SJ, Sun H, Miwa T, Song W, Goke R, and Chen YH (2006) Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 177:8095-8102.
20. Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D'Esposito M, Di Lauro R, and Verde P (2009) An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28:73-84.
21. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, and Li Y (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27:4373-4379.
22. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, and Pagano M (2006) S6K1-and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314:467-471.
23. Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R, and Goke R (2004) Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol Cell Endocrinol 214:149-153.
24. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, and Allgayer H (2007) Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26:4550-4562.
25. Santhanam AN, Baker RA, Hegamyer, G, Kirschmann DA, and Colburn NH PDCD4 repression of Lysyl Oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene (in press) Lysyl oxidase is a PDCD4 target that links inflammation, oxidant stress, and invasion.
26. Akira S and Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
27. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, et al. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110:1330-1333.
28. Blees JS, Schmid T, Thomas CL, Baker AR, Benson L, Evans JR, Goncharova EI, Colburn NH, McMahon JB, and Henrich CJ (2010) Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4. J Biomol Screen 15:21-29.